Who owns Silexion Therapeutics Corp? Owners, funding and legal record

Before you sign or pay

• Court and bankruptcy: No federal court case or bankruptcy filing found under Silexion Therapeutics Corp in our court records and SEC 8-K records (as of 2026-10-18).
• Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Moringa Sponsor, LP (filed 2026-09-28).

Who is behind it

Silexion Therapeutics Corp: business address in Ramat Gan, L3; industry Biological Products, (No Diagnostic Substances) (Schedule 13D/A, 2026-09-28).

Officers and directors, each with the role and the filing that names them:

• Ilan Hadar: Executive Officer, Director (Form D, 2025-08-11)
• Mirit Horenshtein-Hadar: Executive Officer (Form D, 2025-08-11)
• Ruth Alon: Director (Form D, 2025-08-11)
• Ilan Levin: Director (Form D, 2025-08-11)
• Avner Lushi: Director (Form D, 2025-08-11)
• Shlomo Noy: Director (Form D, 2025-08-11)
• Amnon Peled: Director (Form D, 2025-08-11)
• Dror Abramov: Director (Form D, 2025-08-11)
• Mitchell Shirvan: Executive Officer (Form D, 2025-08-11)

Money raised

Latest IPO step: Silexion Therapeutics Corp filed its final IPO prospectus (424B4, 2026-08-13).

IPO filings: 424B4, 2026-08-13, S-1/A, 2026-08-10, S-1, 2026-08-07, 424B4, 2025-09-12, S-1, 2025-09-05.

Related pages

5%+ holdersIPO filings

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

All companies

Not for employment, credit, insurance or tenancy decisions.